Phospho-Akt1 (S473) ELISA DYC2289C-2 from R&D Systems, a Bio-Techne Brand | Biocompare.com

Supplier Images

Phospho-Akt1 (S473) ELISA

Phospho-Akt1 (S473) ELISA
Phospho-Akt1 (S473) ELISA
Phospho-Akt1 (S473) ELISA

Be the first to write a review!

Citations:

Supplier Page from
R&D Systems, a Bio-Techne Brand for
Phospho-Akt1 (S473) ELISA

Product Specs
ItemPhospho-Akt1 (S473) ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $495.00Supplier Page View Company Product Page
Catalog NumberDYC2289C-2
NCBI Full Gene NameAKT serine/threonine kinase 1
NCBI Gene AliasesAKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
Detection TargetAkt1
ReactivityHuman, Mouse
ApplicationsELISA
Quantity1 Kit (for 2 Plates)

Specifications/Features

Available conjugates: Sizes Available: 1 Kit (for 2 Plates)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Microfluidic Single-Cell Proteomics Assay Chip: Lung Cancer Cell Line Case StudyMicromachinesSeptember 23, 2021Jung Y, Son M, Nam YR, Choi J, Heath JR, Yang S.

(2) Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrcJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral PathologyOctober 1, 2017Jedlinski A, Garvin S, Johansson AC, Edqvist PH, Ponten F, Roberg K.

(3) Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivoOncotargetSeptember 20, 2016Janssens R, Mortier A, Boff D, Vanheule V, Gouwy M, Franck C, Larsen O, Rosenkilde MM, Van Damme J, Amaral FA, et al.

(4) Stand-Sit Microchip for High-Throughput, Multiplexed Analysis of Single Cancer CellsScientific reportsSeptember 1, 2016Ramirez L, Herschkowitz JI, Wang J.

(5) Real-time monitoring of cisplatin-induced cell deathPloS oneJanuary 1, 2011Alborzinia H, Can S, Holenya P, Scholl C, Lederer E, Kitanovic I, Wölfl S.

(6) Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migrationBloodJuly 1, 2007Proost P, Mortier A, Loos T, Vandercappellen J, Gouwy M, Ronsse I, Schutyser E, Put W, Parmentier M, Struyf S, et al.

Be the First to Write a Review!